Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting

Summary

Tarsus Pharmaceuticals plans to present 11 abstracts on demodex blepharitis, ocular rosacea, and real-world XDEMVY data at the American Academy of Optometry 2026 Annual Meeting. This represents a routine conference presentation highlighting product insights and clinical outcomes.